Invention Grant
- Patent Title: Controllable transcription
-
Application No.: US16463829Application Date: 2017-11-24
-
Publication No.: US11697823B2Publication Date: 2023-07-11
- Inventor: Ludovic Vallier , Mark Kotter , Matthias Pawlowski , Alessandro Bertero , Daniel Ortmann
- Applicant: Cambridge Enterprise Limited (GB/GB)
- Applicant Address: GB Cambridgeshire
- Assignee: Cambridge Enterprise Limited
- Current Assignee: Cambridge Enterprise Limited
- Current Assignee Address: GB Cambridge
- Agency: Goodwin Procter LLP
- Priority: GB 19876 2016.11.24
- International Application: PCT/GB2017/053531 2017.11.24
- International Announcement: WO2018/096343A 2018.05.31
- Date entered country: 2019-05-23
- Main IPC: C12N15/63
- IPC: C12N15/63 ; C12N15/79 ; C07H21/04 ; C12N15/86 ; A61K35/545 ; C12N5/0735 ; C12N5/074 ; C12N5/079 ; C12N5/077 ; C12N9/22 ; C12N15/11 ; G01N33/50

Abstract:
The present invention relates to a stable method for introducing at least one inducible cassette into a cell, and permitting controllable transcription from within that inducible cassette. The method may be used for any cell type, from any eukaryotic organism, but has a particular application in the introduction of inducible cassettes into pluripotent stem cells, such as animal or human pluripotent stem cells (hPSCs). The inducible cassette is controllably inserted in such a way to ensure that the genetic material it contains is not silenced or subject to negative influences from the insertion site, and transcription of the genetic material is controlled.
Public/Granted literature
- US20190338309A1 CONTROLLABLE TRANSCRIPTION Public/Granted day:2019-11-07
Information query
IPC分类: